版本:
中国

BRIEF-Concert pharmaceuticals announces shareholder approval of CTP-656 asset purchase agreement with Vertex Pharmaceuticals

May 24 Concert Pharmaceuticals Inc

* Concert pharmaceuticals announces shareholder approval of CTP-656 asset purchase agreement with Vertex Pharmaceuticals

* Vertex will pay concert $160 million in cash for all worldwide development and commercialization rights to CTP-656

* Concert continues to expect transaction to close by October 31, 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐